Investors sold shares of Humana Inc. (NYSE:HUM) on strength during trading hours on Friday after Royal Bank Of Canada lowered their price target on the stock from $222.00 to $217.00. $50.62 million flowed into the stock on the tick-up and $92.80 million flowed out of the stock on the tick-down, for a money net flow of $42.18 million out of the stock. Of all stocks tracked, Humana had the 22nd highest net out-flow for the day. Humana traded up $1.34 for the day and closed at $170.82
HUM has been the topic of several other research reports. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 price target on the stock in a research note on Tuesday, October 4th. Credit Suisse Group AG restated a “hold” rating on shares of Humana in a research note on Tuesday, June 28th. Cantor Fitzgerald restated a “buy” rating on shares of Humana in a research note on Saturday, July 9th. Leerink Swann restated an “outperform” rating on shares of Humana in a research note on Tuesday, June 21st. Finally, Wolfe Research upgraded shares of Humana to an “outperform” rating and set a $192.00 price target on the stock in a research note on Thursday, July 21st. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $200.50.
Large investors have recently made changes to their positions in the company. Virginia Retirement System purchased a new stake in shares of Humana during the first quarter worth about $440,000. NN Investment Partners Holdings N.V. purchased a new position in Humana during the first quarter valued at $3,104,000. Bessemer Group Inc. raised its position in Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares during the last quarter. Spark Investment Management LLC purchased a new position in Humana during the first quarter valued at $274,000. Finally, Aviva PLC raised its position in Humana by 1.9% in the first quarter. Aviva PLC now owns 86,580 shares of the insurance provider’s stock valued at $15,840,000 after buying an additional 1,632 shares during the last quarter. Institutional investors and hedge funds own 93.24% of the company’s stock.
The firm has a 50-day moving average of $176.12 and a 200-day moving average of $175.83. The stock has a market cap of $25.46 billion, a price-to-earnings ratio of 26.24 and a beta of 0.90.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The business earned $14 billion during the quarter, compared to analysts’ expectations of $13.59 billion. During the same quarter in the prior year, the business posted $1.67 earnings per share. Humana’s revenue was up 2.0% compared to the same quarter last year. On average, equities research analysts forecast that Humana Inc. will post $9.24 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 annualized dividend and a yield of 0.68%. Humana’s dividend payout ratio is 18.18%.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.